739
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Idiotype-specific intravenous immunoglobulin for therapy of immunoglobulin kappa free light chain deficiency

, &
Pages 1123-1125 | Received 20 Nov 2018, Accepted 13 Jan 2019, Published online: 19 Mar 2019

References

  • US Food and Drug Administration [ accessed 2018 Sept 25]. https://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm133691.htm.
  • Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, Dorsey M, El-Gamal Y, Harville TO, Hossny E, Mazer B, et al. Update on the use of immunoglobulin in human disease: A review of evidence. J Allergy Clin Immunol. 2017;139(3S):S1–S46. doi:10.1016/j.jaci.2016.09.023.
  • Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol. 2009;145(6):709–27. doi:10.1111/j.1365-2141.2009.07669.x.
  • Cunningham-Rundles C. How I treat common variable immune deficiency. Blood. 2010;116(1):7–15. doi:10.1182/blood-2010-01-254417.
  • Orange JS. Considering the demand for and prioritization of intravenous immunoglobulin. Clin Exp Immunol. 2014;178(Suppl 1):78–82. doi:10.1111/cei.12520.
  • Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia. 2009;23:215–24. doi:10.1038/leu.2008.307.
  • Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA. Serum reference intervals and diagnostic ranges for free k and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem. 2002;48(9):1437–44.
  • Bernier GM, Gunderman JR, Ruymann FB. Kappa-chain deficiency. Blood. 1972;40:795e805.
  • Unsworth DJ, Wallage MJ, Sarkar E, Lock RJ. Abnormalities of serum-free light chain in patients with primary antibody deficiency in the absence of B lymphocyte clonality. J Clin Pathol. 2012;65(12):1128–31. doi:10.1136/jclinpath-2012-201044.
  • Sala P, Colatutto A, Fabbro D, Mariuzzi L, Marzinotto S, Toffoletto B, Perosa AR, Damante G. Immunoglobulin K light chain deficiency: A rare, but probably underestimated, humoral immune defect. Eur J Med Genet. 2016;59(4):219–22. doi:10.1016/j.ejmg.2016.02.003.
  • Stanciu AE, Sava F, Toldi G. A rare case of polyglandular autoimmune syndrome type IIIc with primary antibody failure. Gynecol Endocrinol. 2018;34(4):283–85. doi:10.1080/09513590.2017.1391775.
  • Frenzel W, Wietek S, Svae TE, Debes A, Svorc D. Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials. Int J Clin Pharmacol Ther. 2016;54(11):847–55. doi:10.5414/CP202782.
  • Durandi DA, Kaveri SV, Kuijpers TW, Basta M, Miescher S, Ravetch JV, Rieben R. Intravenous immunoglobulins – understanding properties and mechanisms. Clin Exp Immunol. 2009;158(Suppl 1):2–13. doi:10.1111/j.1365-2249.2009.04022.x.
  • Bräuninger A, Goossens T, Rajewsky K, Küppers R. Regulation of immunoglobulin light chain gene rearrangements during early B cell development in the human. Eur J Immunol. 2001;31(12):3631–37. doi:10.1002/1521-4141(200112)31:12<3631::AID-IMMU3631>3.0.CO;2-L.
  • Murphy K, Weaver C. Janeway’s immunobiology. 9th ed. New York (NY): Garland Science/Taylor & Francis Group, LLC; 2016.
  • Fraser LD, Zhao Y, Lutalo PM, D’Cruz DP, Cason J, Silva JS, Dunn-Walters DK, Nayar S, Cope AP, Spencer J. Immunoglobulin light chain allelic inclusion in systemic lupus erythematosus. Eur J Immunol. 2015;45(8):2409–19. doi:10.1002/eji.201545599.
  • Bendandi M. Idiotype vaccination. In: Schwab M, editor. Encyclopedia of Cancer. Berlin (Heidelberg): Springer; 2011, (pp. 32–68).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.